Research Archive — Page 26 of 139

Grayscale 3D medical illustration of a person holding their head, with the brain and branching blood vessels shown in red.
January 6, 2025

VUMC study shows identifying changes in vision may be sufficient to diagnose mild TBI

In both military and civilian populations, when TBI patients are asked to fill out a symptom inventory, about 80% of them will self-report difficulty reading or other vision problems.

Black silhouette of a person standing against a textured grayscale watercolor background.
January 3, 2025

AI tested for alerting clinicians of suicide risk at three VUMC clinics

At neurology clinics the system was used to flag 8% of arriving patients as having relatively high risk for suicide attempt in the next 30 days.

3D anatomical illustration of a human torso showing the liver highlighted in bright orange beneath the rib cage, with surrounding abdominal organs rendered translucently.
December 19, 2024

Proteomic signature a key to early detection of fatty liver disease: study

Currently, methods to detect early, obesity-related accumulation of fat in the liver other than a liver biopsy — the surgical removal of liver tissue for microscopic examination — are limited. But there is hope.

Pink and yellow measuring tapes arranged in looping curves on a light cyan background.
December 18, 2024

VUMC part of multisite team investigating genetic markers of anorexia nervosa

With funding from the newly established Sarah Kyle Anorexia Nervosa Research Foundation, the researchers hope to identify biomarkers that will point to novel targets for prevention and treatment.

Illustration of a spherical parainfluenza virus particle with a textured orange surface and numerous irregular multicolored spike-like structures, alongside a blurred particle in the foreground.
December 17, 2024

Study shows drop in use of antiviral medications in young children with influenza

Flu illness accounts for up to 10% of all pediatric hospitalizations during the winter season in the United States.

Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
December 17, 2024

Immune-suppressing drug does not improve COVID-19 recovery: study

Previous studies suggested that fostamatinib may suppress inflammatory responses triggered by COVID-19 and mitigate ongoing lung injury, decreasing mortality and oxygen requirements.